Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global 25G Transconjunctival Sutureless Vitrectomy System Market Outlook, In‑Depth Analysis & Forecast to 2032
Global 25G Transconjunctival Sutureless Vitrectomy System Market Outlook, In‑Depth Analysis & Forecast to 2032
Industry: Medical Devices & Consumables
Published Date: 2026-03-26
Pages: 132 Pages
Report ld: 6302597
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global 25G Transconjunctival Sutureless Vitrectomy System market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
The 25G transconjunctival sutureless vitrectomy system is a vitrectomy surgery performed with minimal trauma. It uses a special trocar to directly puncture the bulbar conjunctiva and sclera to enter the vitreous cavity for surgery. The surgical incision is significantly reduced and no suture is required, so it is called "minimally traumatic" surgery. The system is mainly composed of microcannulas, cannula puncture needles, perfusion tubes, cannula plugs and plug forceps. Among them, the diameters of the cannulas and surgical instruments are very small, so that only three very small needle holes (0.5 mm in diameter) are needed to pass through the wall of the eyeball. The perfusion tube and surgical instruments are inserted into the eyeball through the cannula, and no sutures are required to fix them.
From a downstream perspective, Ophthalmology accounted for % of 2025 revenue, surging to US$ million by 2032 (CAGR: % from 2026–2032).
25G Transconjunctival Sutureless Vitrectomy System leading manufacturers (including Alcon, Bausch + Lomb, Dutch Ophthalmic Research Center, NIDEK, Suzhou Synergy Medical Technology, Shanghai Fosun Pharmaceutical Group, Beijing Kangruide Medical Technology, Shanghai New Vision Ophthalmic Equipment, Shenzhen Ophthalmic Equipment, etc.), dominate supply; the top five capture approximately % of global revenue, with Alcon leading 2025 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2025 to a forecast US$ million by 2032 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2025, % share rising to % by 2032), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2032 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global 25G Transconjunctival Sutureless Vitrectomy System market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Alcon
- Bausch + Lomb
- Dutch Ophthalmic Research Center
- NIDEK
- Suzhou Synergy Medical Technology
- Shanghai Fosun Pharmaceutical Group
- Beijing Kangruide Medical Technology
- Shanghai New Vision Ophthalmic Equipment
- Shenzhen Ophthalmic Equipment
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Standard
- Combination
Segment by Application
- Ophthalmology
- Other
CHAPTER OUTLINE
Chapter 1: Defines the 25G Transconjunctival Sutureless Vitrectomy System study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to 25G Transconjunctival Sutureless Vitrectomy System: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global 25G Transconjunctival Sutureless Vitrectomy System Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Standard
1.2.3 Combination
1.3 Market Segmentation by Application
1.3.1 Global 25G Transconjunctival Sutureless Vitrectomy System Market Size by Application, 2021 vs 2025 vs 2032
1.3.2 Ophthalmology
1.3.3 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global 25G Transconjunctival Sutureless Vitrectomy System Revenue Estimates and Forecasts (2021-2032)
2.2 Global 25G Transconjunctival Sutureless Vitrectomy System Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Estimates and Forecasts (2021-2032)
2.4 Global 25G Transconjunctival Sutureless Vitrectomy System Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Historical and Forecasted Sales by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2021-2032)
3 Competitive Landscape
3.1 Global 25G Transconjunctival Sutureless Vitrectomy System Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global 25G Transconjunctival Sutureless Vitrectomy System Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 Standard: Market Share by Key Manufacturers
3.5.2 Combination: Market Share by Key Manufacturers
3.6 Global 25G Transconjunctival Sutureless Vitrectomy System Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Product Segmentation
4.1 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Performance by Type
4.1.1 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Volume by Type (2021-2032)
4.1.2 Global 25G Transconjunctival Sutureless Vitrectomy System Revenue by Type (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
4.2 Product Technology Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Downstream Applications and Customers
5.1 Global 25G Transconjunctival Sutureless Vitrectomy System Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
5.1.2 Global Sales Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global 25G Transconjunctival Sutureless Vitrectomy System Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.2.2 Revenue-Based Market Share by Application (2021-2032)
5.3 Global Pricing Dynamics by Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2021-2032)
6.2 North America Key Manufacturers Sales Revenue in 2025
6.3 North America 25G Transconjunctival Sutureless Vitrectomy System Sales and Revenue by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America 25G Transconjunctival Sutureless Vitrectomy System Market Size by Country
6.5.1 North America Revenue by Country
6.5.2 North America Sales Trends by Country
6.5.3 US
6.5.4 Canada
6.5.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2021-2032)
7.2 Europe Key Manufacturers Sales Revenue in 2025
7.3 Europe 25G Transconjunctival Sutureless Vitrectomy System Sales and Revenue by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe 25G Transconjunctival Sutureless Vitrectomy System Market Size by Country
7.5.1 Europe Revenue by Country
7.5.2 Europe Sales Trends by Country
7.5.3 Germany
7.5.4 France
7.5.5 U.K.
7.5.6 Italy
7.5.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
8.3 Asia-Pacific 25G Transconjunctival Sutureless Vitrectomy System Sales and Revenue by Application (2021-2032)
8.4 Asia-Pacific 25G Transconjunctival Sutureless Vitrectomy System Market Size by Region
8.4.1 Asia-Pacific Revenue by Region
8.4.2 Asia-Pacific Sales Trends by Region
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Southeast Asia
8.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
8.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.7 China
8.8 Japan
8.9 South Korea
8.10 China Taiwan
8.11 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2021-2032)
9.2 Central and South America Key Manufacturers Sales Revenue in 2025
9.3 Central and South America 25G Transconjunctival Sutureless Vitrectomy System Sales and Revenue by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America 25G Transconjunctival Sutureless Vitrectomy System Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
10.3 Middle East and Africa 25G Transconjunctival Sutureless Vitrectomy System Sales and Revenue by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa 25G Transconjunctival Sutureless Vitrectomy System Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Turkey
10.5.4 Egypt
10.5.5 South Africa
11 Corporate Profile
11.1 Alcon
11.1.1 Alcon Corporation Information
11.1.2 Alcon Business Overview
11.1.3 Alcon 25G Transconjunctival Sutureless Vitrectomy System Product Models, Descriptions and Specifications
11.1.4 Alcon 25G Transconjunctival Sutureless Vitrectomy System Sales, Price, Revenue and Gross Margin (2021-2026)
11.1.5 Alcon 25G Transconjunctival Sutureless Vitrectomy System Sales by Product in 2025
11.1.6 Alcon 25G Transconjunctival Sutureless Vitrectomy System Sales by Application in 2025
11.1.7 Alcon 25G Transconjunctival Sutureless Vitrectomy System Sales by Geographic Area in 2025
11.1.8 Alcon 25G Transconjunctival Sutureless Vitrectomy System SWOT Analysis
11.1.9 Alcon Recent Developments
11.2 Bausch + Lomb
11.2.1 Bausch + Lomb Corporation Information
11.2.2 Bausch + Lomb Business Overview
11.2.3 Bausch + Lomb 25G Transconjunctival Sutureless Vitrectomy System Product Models, Descriptions and Specifications
11.2.4 Bausch + Lomb 25G Transconjunctival Sutureless Vitrectomy System Sales, Price, Revenue and Gross Margin (2021-2026)
11.2.5 Bausch + Lomb 25G Transconjunctival Sutureless Vitrectomy System Sales by Product in 2025
11.2.6 Bausch + Lomb 25G Transconjunctival Sutureless Vitrectomy System Sales by Application in 2025
11.2.7 Bausch + Lomb 25G Transconjunctival Sutureless Vitrectomy System Sales by Geographic Area in 2025
11.2.8 Bausch + Lomb 25G Transconjunctival Sutureless Vitrectomy System SWOT Analysis
11.2.9 Bausch + Lomb Recent Developments
11.3 Dutch Ophthalmic Research Center
11.3.1 Dutch Ophthalmic Research Center Corporation Information
11.3.2 Dutch Ophthalmic Research Center Business Overview
11.3.3 Dutch Ophthalmic Research Center 25G Transconjunctival Sutureless Vitrectomy System Product Models, Descriptions and Specifications
11.3.4 Dutch Ophthalmic Research Center 25G Transconjunctival Sutureless Vitrectomy System Sales, Price, Revenue and Gross Margin (2021-2026)
11.3.5 Dutch Ophthalmic Research Center 25G Transconjunctival Sutureless Vitrectomy System Sales by Product in 2025
11.3.6 Dutch Ophthalmic Research Center 25G Transconjunctival Sutureless Vitrectomy System Sales by Application in 2025
11.3.7 Dutch Ophthalmic Research Center 25G Transconjunctival Sutureless Vitrectomy System Sales by Geographic Area in 2025
11.3.8 Dutch Ophthalmic Research Center 25G Transconjunctival Sutureless Vitrectomy System SWOT Analysis
11.3.9 Dutch Ophthalmic Research Center Recent Developments
11.4 NIDEK
11.4.1 NIDEK Corporation Information
11.4.2 NIDEK Business Overview
11.4.3 NIDEK 25G Transconjunctival Sutureless Vitrectomy System Product Models, Descriptions and Specifications
11.4.4 NIDEK 25G Transconjunctival Sutureless Vitrectomy System Sales, Price, Revenue and Gross Margin (2021-2026)
11.4.5 NIDEK 25G Transconjunctival Sutureless Vitrectomy System Sales by Product in 2025
11.4.6 NIDEK 25G Transconjunctival Sutureless Vitrectomy System Sales by Application in 2025
11.4.7 NIDEK 25G Transconjunctival Sutureless Vitrectomy System Sales by Geographic Area in 2025
11.4.8 NIDEK 25G Transconjunctival Sutureless Vitrectomy System SWOT Analysis
11.4.9 NIDEK Recent Developments
11.5 Suzhou Synergy Medical Technology
11.5.1 Suzhou Synergy Medical Technology Corporation Information
11.5.2 Suzhou Synergy Medical Technology Business Overview
11.5.3 Suzhou Synergy Medical Technology 25G Transconjunctival Sutureless Vitrectomy System Product Models, Descriptions and Specifications
11.5.4 Suzhou Synergy Medical Technology 25G Transconjunctival Sutureless Vitrectomy System Sales, Price, Revenue and Gross Margin (2021-2026)
11.5.5 Suzhou Synergy Medical Technology 25G Transconjunctival Sutureless Vitrectomy System Sales by Product in 2025
11.5.6 Suzhou Synergy Medical Technology 25G Transconjunctival Sutureless Vitrectomy System Sales by Application in 2025
11.5.7 Suzhou Synergy Medical Technology 25G Transconjunctival Sutureless Vitrectomy System Sales by Geographic Area in 2025
11.5.8 Suzhou Synergy Medical Technology 25G Transconjunctival Sutureless Vitrectomy System SWOT Analysis
11.5.9 Suzhou Synergy Medical Technology Recent Developments
11.6 Shanghai Fosun Pharmaceutical Group
11.6.1 Shanghai Fosun Pharmaceutical Group Corporation Information
11.6.2 Shanghai Fosun Pharmaceutical Group Business Overview
11.6.3 Shanghai Fosun Pharmaceutical Group 25G Transconjunctival Sutureless Vitrectomy System Product Models, Descriptions and Specifications
11.6.4 Shanghai Fosun Pharmaceutical Group 25G Transconjunctival Sutureless Vitrectomy System Sales, Price, Revenue and Gross Margin (2021-2026)
11.6.5 Shanghai Fosun Pharmaceutical Group Recent Developments
11.7 Beijing Kangruide Medical Technology
11.7.1 Beijing Kangruide Medical Technology Corporation Information
11.7.2 Beijing Kangruide Medical Technology Business Overview
11.7.3 Beijing Kangruide Medical Technology 25G Transconjunctival Sutureless Vitrectomy System Product Models, Descriptions and Specifications
11.7.4 Beijing Kangruide Medical Technology 25G Transconjunctival Sutureless Vitrectomy System Sales, Price, Revenue and Gross Margin (2021-2026)
11.7.5 Beijing Kangruide Medical Technology Recent Developments
11.8 Shanghai New Vision Ophthalmic Equipment
11.8.1 Shanghai New Vision Ophthalmic Equipment Corporation Information
11.8.2 Shanghai New Vision Ophthalmic Equipment Business Overview
11.8.3 Shanghai New Vision Ophthalmic Equipment 25G Transconjunctival Sutureless Vitrectomy System Product Models, Descriptions and Specifications
11.8.4 Shanghai New Vision Ophthalmic Equipment 25G Transconjunctival Sutureless Vitrectomy System Sales, Price, Revenue and Gross Margin (2021-2026)
11.8.5 Shanghai New Vision Ophthalmic Equipment Recent Developments
11.9 Shenzhen Ophthalmic Equipment
11.9.1 Shenzhen Ophthalmic Equipment Corporation Information
11.9.2 Shenzhen Ophthalmic Equipment Business Overview
11.9.3 Shenzhen Ophthalmic Equipment 25G Transconjunctival Sutureless Vitrectomy System Product Models, Descriptions and Specifications
11.9.4 Shenzhen Ophthalmic Equipment 25G Transconjunctival Sutureless Vitrectomy System Sales, Price, Revenue and Gross Margin (2021-2026)
11.9.5 Shenzhen Ophthalmic Equipment Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 25G Transconjunctival Sutureless Vitrectomy System Industry Chain
12.2 25G Transconjunctival Sutureless Vitrectomy System Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 25G Transconjunctival Sutureless Vitrectomy System Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2021-2032)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 25G Transconjunctival Sutureless Vitrectomy System Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 25G Transconjunctival Sutureless Vitrectomy System Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
13.4 Impact of U.S. Tariffs
14 Key Findings in the Global 25G Transconjunctival Sutureless Vitrectomy System Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global 25G Transconjunctival Sutureless Vitrectomy System Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global 25G Transconjunctival Sutureless Vitrectomy System Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global 25G Transconjunctival Sutureless Vitrectomy System Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global 25G Transconjunctival Sutureless Vitrectomy System Revenue by Region (US$ Million), 2021-2026
Table 5. Global 25G Transconjunctival Sutureless Vitrectomy System Revenue by Region (US$ Million), 2027-2032
Table 6. Global 25G Transconjunctival Sutureless Vitrectomy System Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (Units)
Table 7. Global 25G Transconjunctival Sutureless Vitrectomy System Sales by Region (Units), 2021-2026
Table 8. Global 25G Transconjunctival Sutureless Vitrectomy System Sales by Region (Units), 2027-2032
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 10. Global 25G Transconjunctival Sutureless Vitrectomy System Sales by Manufacturers (Units), 2021-2026
Table 11. Global 25G Transconjunctival Sutureless Vitrectomy System Sales Share by Manufacturers (2021-2026)
Table 12. Global 25G Transconjunctival Sutureless Vitrectomy System Revenue by Manufacturers (US$ Million), 2021-2026
Table 13. Global 25G Transconjunctival Sutureless Vitrectomy System Revenue-Based Market Share by Manufacturers (2021-2026)
Table 14. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)
Table 15. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on 25G Transconjunctival Sutureless Vitrectomy System Revenue, 2025
Table 16. Global 25G Transconjunctival Sutureless Vitrectomy System Average Gross Margin (%) by Manufacturer (2021 vs 2025)
Table 17. Global 25G Transconjunctival Sutureless Vitrectomy System Average Selling Price (ASP) by Manufacturers (K US$/Unit), 2021-2026
Table 18. Key Manufacturers 25G Transconjunctival Sutureless Vitrectomy System Manufacturing Base and Headquarters
Table 19. Global 25G Transconjunctival Sutureless Vitrectomy System Market Concentration Ratio (CR5)
Table 20. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global 25G Transconjunctival Sutureless Vitrectomy System Sales Volume by Type (Units), 2021-2026
Table 23. Global 25G Transconjunctival Sutureless Vitrectomy System Sales Volume by Type (Units), 2027-2032
Table 24. Global 25G Transconjunctival Sutureless Vitrectomy System Revenue by Type (US$ Million), 2021-2026
Table 25. Global 25G Transconjunctival Sutureless Vitrectomy System Revenue by Type (US$ Million), 2027-2032
Table 26. Technical Specifications by Key Product Type
Table 27. Global 25G Transconjunctival Sutureless Vitrectomy System Sales by Application (Units), 2021-2026
Table 28. Global 25G Transconjunctival Sutureless Vitrectomy System Sales by Application (Units), 2027-2032
Table 29. 25G Transconjunctival Sutureless Vitrectomy System High-Growth Sectors Demand CAGR (2026-2032)
Table 30. Global 25G Transconjunctival Sutureless Vitrectomy System Revenue by Application (US$ Million), 2021-2026
Table 31. Global 25G Transconjunctival Sutureless Vitrectomy System Revenue by Application (US$ Million), 2027-2032
Table 32. Top Customers by Region
Table 33. Top Customers by Application
Table 34. North America 25G Transconjunctival Sutureless Vitrectomy System Growth Accelerators and Market Barriers
Table 35. North America 25G Transconjunctival Sutureless Vitrectomy System Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 36. North America 25G Transconjunctival Sutureless Vitrectomy System Sales (Units) by Country (2021 vs 2025 vs 2032)
Table 37. Europe 25G Transconjunctival Sutureless Vitrectomy System Growth Accelerators and Market Barriers
Table 38. Europe 25G Transconjunctival Sutureless Vitrectomy System Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 39. Europe 25G Transconjunctival Sutureless Vitrectomy System Sales (Units) by Country (2021 vs 2025 vs 2032)
Table 40. Asia-Pacific 25G Transconjunctival Sutureless Vitrectomy System Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Asia-Pacific 25G Transconjunctival Sutureless Vitrectomy System Sales (Units) by Country (2021 vs 2025 vs 2032)
Table 42. Asia-Pacific 25G Transconjunctival Sutureless Vitrectomy System Growth Accelerators and Market Barriers
Table 43. Southeast Asia 25G Transconjunctival Sutureless Vitrectomy System Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 44. Central and South America 25G Transconjunctival Sutureless Vitrectomy System Investment Opportunities and Key Challenges
Table 45. Central and South America 25G Transconjunctival Sutureless Vitrectomy System Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 46. Middle East and Africa 25G Transconjunctival Sutureless Vitrectomy System Investment Opportunities and Key Challenges
Table 47. Middle East and Africa 25G Transconjunctival Sutureless Vitrectomy System Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 48. Alcon Corporation Information
Table 49. Alcon Description and Major Businesses
Table 50. Alcon Product Models, Descriptions and Specifications
Table 51. Alcon Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 52. Alcon Sales Value Proportion by Product in 2025
Table 53. Alcon Sales Value Proportion by Application in 2025
Table 54. Alcon Sales Value Proportion by Geographic Area in 2025
Table 55. Alcon 25G Transconjunctival Sutureless Vitrectomy System SWOT Analysis
Table 56. Alcon Recent Developments
Table 57. Bausch + Lomb Corporation Information
Table 58. Bausch + Lomb Description and Major Businesses
Table 59. Bausch + Lomb Product Models, Descriptions and Specifications
Table 60. Bausch + Lomb Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 61. Bausch + Lomb Sales Value Proportion by Product in 2025
Table 62. Bausch + Lomb Sales Value Proportion by Application in 2025
Table 63. Bausch + Lomb Sales Value Proportion by Geographic Area in 2025
Table 64. Bausch + Lomb 25G Transconjunctival Sutureless Vitrectomy System SWOT Analysis
Table 65. Bausch + Lomb Recent Developments
Table 66. Dutch Ophthalmic Research Center Corporation Information
Table 67. Dutch Ophthalmic Research Center Description and Major Businesses
Table 68. Dutch Ophthalmic Research Center Product Models, Descriptions and Specifications
Table 69. Dutch Ophthalmic Research Center Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 70. Dutch Ophthalmic Research Center Sales Value Proportion by Product in 2025
Table 71. Dutch Ophthalmic Research Center Sales Value Proportion by Application in 2025
Table 72. Dutch Ophthalmic Research Center Sales Value Proportion by Geographic Area in 2025
Table 73. Dutch Ophthalmic Research Center 25G Transconjunctival Sutureless Vitrectomy System SWOT Analysis
Table 74. Dutch Ophthalmic Research Center Recent Developments
Table 75. NIDEK Corporation Information
Table 76. NIDEK Description and Major Businesses
Table 77. NIDEK Product Models, Descriptions and Specifications
Table 78. NIDEK Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 79. NIDEK Sales Value Proportion by Product in 2025
Table 80. NIDEK Sales Value Proportion by Application in 2025
Table 81. NIDEK Sales Value Proportion by Geographic Area in 2025
Table 82. NIDEK 25G Transconjunctival Sutureless Vitrectomy System SWOT Analysis
Table 83. NIDEK Recent Developments
Table 84. Suzhou Synergy Medical Technology Corporation Information
Table 85. Suzhou Synergy Medical Technology Description and Major Businesses
Table 86. Suzhou Synergy Medical Technology Product Models, Descriptions and Specifications
Table 87. Suzhou Synergy Medical Technology Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 88. Suzhou Synergy Medical Technology Sales Value Proportion by Product in 2025
Table 89. Suzhou Synergy Medical Technology Sales Value Proportion by Application in 2025
Table 90. Suzhou Synergy Medical Technology Sales Value Proportion by Geographic Area in 2025
Table 91. Suzhou Synergy Medical Technology 25G Transconjunctival Sutureless Vitrectomy System SWOT Analysis
Table 92. Suzhou Synergy Medical Technology Recent Developments
Table 93. Shanghai Fosun Pharmaceutical Group Corporation Information
Table 94. Shanghai Fosun Pharmaceutical Group Description and Major Businesses
Table 95. Shanghai Fosun Pharmaceutical Group Product Models, Descriptions and Specifications
Table 96. Shanghai Fosun Pharmaceutical Group Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 97. Shanghai Fosun Pharmaceutical Group Recent Developments
Table 98. Beijing Kangruide Medical Technology Corporation Information
Table 99. Beijing Kangruide Medical Technology Description and Major Businesses
Table 100. Beijing Kangruide Medical Technology Product Models, Descriptions and Specifications
Table 101. Beijing Kangruide Medical Technology Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 102. Beijing Kangruide Medical Technology Recent Developments
Table 103. Shanghai New Vision Ophthalmic Equipment Corporation Information
Table 104. Shanghai New Vision Ophthalmic Equipment Description and Major Businesses
Table 105. Shanghai New Vision Ophthalmic Equipment Product Models, Descriptions and Specifications
Table 106. Shanghai New Vision Ophthalmic Equipment Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 107. Shanghai New Vision Ophthalmic Equipment Recent Developments
Table 108. Shenzhen Ophthalmic Equipment Corporation Information
Table 109. Shenzhen Ophthalmic Equipment Description and Major Businesses
Table 110. Shenzhen Ophthalmic Equipment Product Models, Descriptions and Specifications
Table 111. Shenzhen Ophthalmic Equipment Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 112. Shenzhen Ophthalmic Equipment Recent Developments
Table 113. Key Raw Materials Distribution
Table 114. Raw Materials Key Suppliers
Table 115. Critical Raw Material Supplier Concentration (2025) & Risk Index
Table 116. Milestones in Production Technology Evolution
Table 117. Distributors List
Table 118. Market Trends and Market Evolution
Table 119. Market Drivers and Opportunities
Table 120. Market Challenges, Risks, and Restraints
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. 25G Transconjunctival Sutureless Vitrectomy System Product Picture
Figure 2. Global 25G Transconjunctival Sutureless Vitrectomy System Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Standard Product Picture
Figure 4. Combination Product Picture
Figure 5. Global 25G Transconjunctival Sutureless Vitrectomy System Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 6. Ophthalmology
Figure 7. Other
Figure 8. 25G Transconjunctival Sutureless Vitrectomy System Report Years Considered
Figure 9. Global 25G Transconjunctival Sutureless Vitrectomy System Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 10. Global 25G Transconjunctival Sutureless Vitrectomy System Revenue (US$ Million), 2021-2032
Figure 11. Global 25G Transconjunctival Sutureless Vitrectomy System Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 12. Global 25G Transconjunctival Sutureless Vitrectomy System Revenue-Based Market Share by Region (2021-2032)
Figure 13. Global 25G Transconjunctival Sutureless Vitrectomy System Sales (Units), 2021-2032
Figure 14. Global 25G Transconjunctival Sutureless Vitrectomy System Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (Units)
Figure 15. Global 25G Transconjunctival Sutureless Vitrectomy System Sales Market Share by Region (2021-2032)
Figure 16. Top 5 and Top 10 Manufacturers 25G Transconjunctival Sutureless Vitrectomy System Sales Volume Market Share in 2025
Figure 17. Global 25G Transconjunctival Sutureless Vitrectomy System Revenue-Based Market Share Ranking (2025)
Figure 18. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 19. Standard Revenue-Based Market Share by Manufacturer in 2025
Figure 20. Combination Revenue-Based Market Share by Manufacturer in 2025
Figure 21. Global 25G Transconjunctival Sutureless Vitrectomy System Sales Volume-Based Market Share by Type (2021-2032)
Figure 22. Global 25G Transconjunctival Sutureless Vitrectomy System Revenue-Based Market Share by Type (2021-2032)
Figure 23. Global 25G Transconjunctival Sutureless Vitrectomy System ASP by Type (K US$/Unit), 2021-2032
Figure 24. Global 25G Transconjunctival Sutureless Vitrectomy System Revenue-Based Market Share (2021-2032)
Figure 25. Global 25G Transconjunctival Sutureless Vitrectomy System Sales Market Share by Application (2021-2032)
Figure 26. Global 25G Transconjunctival Sutureless Vitrectomy System Revenue-Based Market Share by Application (2021-2032)
Figure 27. Global 25G Transconjunctival Sutureless Vitrectomy System ASP by Application (K US$/Unit), 2021-2032
Figure 28. North America 25G Transconjunctival Sutureless Vitrectomy System Sales YoY (Units), 2021-2032
Figure 29. North America 25G Transconjunctival Sutureless Vitrectomy System Revenue YoY (US$ Million), 2021-2032
Figure 30. North America Top 5 Manufacturers 25G Transconjunctival Sutureless Vitrectomy System Sales Revenue (US$ Million) in 2025
Figure 31. North America 25G Transconjunctival Sutureless Vitrectomy System Sales Volume (Units) by Application (2021-2032)
Figure 32. North America 25G Transconjunctival Sutureless Vitrectomy System Sales Revenue (US$ Million) by Application (2021-2032)
Figure 33. US 25G Transconjunctival Sutureless Vitrectomy System Revenue (US$ Million), 2021-2032
Figure 34. Canada 25G Transconjunctival Sutureless Vitrectomy System Revenue (US$ Million), 2021-2032
Figure 35. Mexico 25G Transconjunctival Sutureless Vitrectomy System Revenue (US$ Million), 2021-2032
Figure 36. Europe 25G Transconjunctival Sutureless Vitrectomy System Sales YoY (Units), 2021-2032
Figure 37. Europe 25G Transconjunctival Sutureless Vitrectomy System Revenue YoY (US$ Million), 2021-2032
Figure 38. Europe Top 5 Manufacturers 25G Transconjunctival Sutureless Vitrectomy System Sales Revenue (US$ Million) in 2025
Figure 39. Europe 25G Transconjunctival Sutureless Vitrectomy System Sales Volume (Units) by Application (2021-2032)
Figure 40. Europe 25G Transconjunctival Sutureless Vitrectomy System Sales Revenue (US$ Million) by Application (2021-2032)
Figure 41. Germany 25G Transconjunctival Sutureless Vitrectomy System Revenue (US$ Million), 2021-2032
Figure 42. France 25G Transconjunctival Sutureless Vitrectomy System Revenue (US$ Million), 2021-2032
Figure 43. U.K. 25G Transconjunctival Sutureless Vitrectomy System Revenue (US$ Million), 2021-2032
Figure 44. Italy 25G Transconjunctival Sutureless Vitrectomy System Revenue (US$ Million), 2021-2032
Figure 45. Russia 25G Transconjunctival Sutureless Vitrectomy System Revenue (US$ Million), 2021-2032
Figure 46. Asia-Pacific 25G Transconjunctival Sutureless Vitrectomy System Sales YoY (Units), 2021-2032
Figure 47. Asia-Pacific 25G Transconjunctival Sutureless Vitrectomy System Revenue YoY (US$ Million), 2021-2032
Figure 48. Asia-Pacific Top 8 Manufacturers 25G Transconjunctival Sutureless Vitrectomy System Sales Revenue (US$ Million) in 2025
Figure 49. Asia-Pacific 25G Transconjunctival Sutureless Vitrectomy System Sales Volume (Units) by Application (2021-2032)
Figure 50. Asia-Pacific 25G Transconjunctival Sutureless Vitrectomy System Sales Revenue (US$ Million) by Application (2021-2032)
Figure 51. Indonesia 25G Transconjunctival Sutureless Vitrectomy System Revenue (US$ Million), 2021-2032
Figure 52. Japan 25G Transconjunctival Sutureless Vitrectomy System Revenue (US$ Million), 2021-2032
Figure 53. South Korea 25G Transconjunctival Sutureless Vitrectomy System Revenue (US$ Million), 2021-2032
Figure 54. China Taiwan 25G Transconjunctival Sutureless Vitrectomy System Revenue (US$ Million), 2021-2032
Figure 55. India 25G Transconjunctival Sutureless Vitrectomy System Revenue (US$ Million), 2021-2032
Figure 56. Central and South America 25G Transconjunctival Sutureless Vitrectomy System Sales YoY (Units), 2021-2032
Figure 57. Central and South America 25G Transconjunctival Sutureless Vitrectomy System Revenue YoY (US$ Million), 2021-2032
Figure 58. Central and South America Top 5 Manufacturers 25G Transconjunctival Sutureless Vitrectomy System Sales Revenue (US$ Million) in 2025
Figure 59. Central and South America 25G Transconjunctival Sutureless Vitrectomy System Sales Volume (Units) by Application (2021-2032)
Figure 60. Central and South America 25G Transconjunctival Sutureless Vitrectomy System Sales Revenue (US$ Million) by Application (2021-2032)
Figure 61. Brazil 25G Transconjunctival Sutureless Vitrectomy System Revenue (US$ Million), 2021-2032
Figure 62. Argentina 25G Transconjunctival Sutureless Vitrectomy System Revenue (US$ Million), 2021-2032
Figure 63. Middle East, and Africa 25G Transconjunctival Sutureless Vitrectomy System Sales YoY (Units), 2021-2032
Figure 64. Middle East and Africa 25G Transconjunctival Sutureless Vitrectomy System Revenue YoY (US$ Million), 2021-2032
Figure 65. Middle East and Africa Top 5 Manufacturers 25G Transconjunctival Sutureless Vitrectomy System Sales Revenue (US$ Million) in 2025
Figure 66. Middle East and Africa 25G Transconjunctival Sutureless Vitrectomy System Sales Volume (Units) by Application (2021-2032)
Figure 67. Middle East and Africa 25G Transconjunctival Sutureless Vitrectomy System Sales Revenue (US$ Million) by Application (2021-2032)
Figure 68. GCC Countries 25G Transconjunctival Sutureless Vitrectomy System Revenue (US$ Million), 2021-2032
Figure 69. Turkey 25G Transconjunctival Sutureless Vitrectomy System Revenue (US$ Million), 2021-2032
Figure 70. Egypt 25G Transconjunctival Sutureless Vitrectomy System Revenue (US$ Million), 2021-2032
Figure 71. South Africa 25G Transconjunctival Sutureless Vitrectomy System Revenue (US$ Million), 2021-2032
Figure 72. 25G Transconjunctival Sutureless Vitrectomy System Industry Chain Mapping
Figure 73. Regional 25G Transconjunctival Sutureless Vitrectomy System Manufacturing Base Distribution (%)
Figure 74. Global 25G Transconjunctival Sutureless Vitrectomy System Production Market Share by Region (2021-2032)
Figure 75. 25G Transconjunctival Sutureless Vitrectomy System Production Process
Figure 76. Regional 25G Transconjunctival Sutureless Vitrectomy System Production Cost Structure
Figure 77. Channels of Distribution (Direct Vs Distribution)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global 25G Transconjunctival Sutureless Vitrectomy System market?
The top companies in the global 25G Transconjunctival Sutureless Vitrectomy System market are Alcon、Bausch + Lomb、Dutch Ophthalmic Research Center.
Related Reports
Global 25G Transconjunctival Sutureless Vitrectomy System Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global 25G Transconjunctival Sutureless Vitrectomy System market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 77
USD 4250.00
(Single User License)
25G Transconjunctival Sutureless Vitrectomy System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for 25G Transconjunctival Sutureless Vitrectomy System was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-08
Pages: 97
USD 3950.00
(Single User License)
Global 25G Transconjunctival Sutureless Vitrectomy System Market Research Report 2026
The global 25G Transconjunctival Sutureless Vitrectomy System market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-08
Pages: 115
USD 2900.00
(Single User License)
Global 25G Transconjunctival Sutureless Vitrectomy System Market Outlook, In‑Depth Analysis & Forecast to 2031
The global 25G Transconjunctival Sutureless Vitrectomy System market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 141
USD 4900.00
(Single User License)
Global 25G Transconjunctival Sutureless Vitrectomy System Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global 25G Transconjunctival Sutureless Vitrectomy System market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 77
USD 4250.00
(Single User License)
25G Transconjunctival Sutureless Vitrectomy System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for 25G Transconjunctival Sutureless Vitrectomy System was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 98
USD 3950.00
(Single User License)
Global 25G Transconjunctival Sutureless Vitrectomy System Market Research Report 2025
The global market for 25G Transconjunctival Sutureless Vitrectomy System was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 87
USD 2900.00
(Single User License)
Global 25G Transconjunctival Sutureless Vitrectomy System Market Insights, Forecast to 2030
The 25G transconjunctival sutureless vitrectomy system is a vitrectomy surgery performed with minimal trauma. It uses a special trocar to directly puncture the bulbar conjunctiva and sclera to enter the vitreous cavity for surgery. The surgical incision is significantly reduced and no suture is required, so it is called "minimally traumatic" surgery. The system is mainly composed of microcannulas, cannula puncture needles, perfusion tubes, cannula plugs and plug forceps. Among them, the diameters of the cannulas and surgical instruments are very small, so that only three very small needle holes (0.5 mm in diameter) are needed to pass through the wall of the eyeball. The perfusion tube and surgical instruments are inserted into the eyeball through the cannula, and no sutures are required to fix them.
Published Date: 2024-10-31
Pages: 134
USD 4900.00
(Single User License)
25G Transconjunctival Sutureless Vitrectomy System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The 25G transconjunctival sutureless vitrectomy system is a vitrectomy surgery performed with minimal trauma. It uses a special trocar to directly puncture the bulbar conjunctiva and sclera to enter the vitreous cavity for surgery. The surgical incision is significantly reduced and no suture is required, so it is called "minimally traumatic" surgery. The system is mainly composed of microcannulas, cannula puncture needles, perfusion tubes, cannula plugs and plug forceps. Among them, the diameters of the cannulas and surgical instruments are very small, so that only three very small needle holes (0.5 mm in diameter) are needed to pass through the wall of the eyeball. The perfusion tube and surgical instruments are inserted into the eyeball through the cannula, and no sutures are required to fix them.
Published Date: 2024-10-31
Pages: 100
USD 3950.00
(Single User License)
Global 25G Transconjunctival Sutureless Vitrectomy System Market Research Report 2024
The 25G transconjunctival sutureless vitrectomy system is a vitrectomy surgery performed with minimal trauma. It uses a special trocar to directly puncture the bulbar conjunctiva and sclera to enter the vitreous cavity for surgery. The surgical incision is significantly reduced and no suture is required, so it is called "minimally traumatic" surgery. The system is mainly composed of microcannulas, cannula puncture needles, perfusion tubes, cannula plugs and plug forceps. Among them, the diameters of the cannulas and surgical instruments are very small, so that only three very small needle holes (0.5 mm in diameter) are needed to pass through the wall of the eyeball. The perfusion tube and surgical instruments are inserted into the eyeball through the cannula, and no sutures are required to fix them.
Published Date: 2024-10-31
Pages: 80
USD 2900.00
(Single User License)
Global 25G Transconjunctival Sutureless Vitrectomy System Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global 25G Transconjunctival Sutureless Vitrectomy System market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 77
USD 4250.00 (Single User License)25G Transconjunctival Sutureless Vitrectomy System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for 25G Transconjunctival Sutureless Vitrectomy System was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-08
Pages: 97
USD 3950.00 (Single User License)Global 25G Transconjunctival Sutureless Vitrectomy System Market Research Report 2026
The global 25G Transconjunctival Sutureless Vitrectomy System market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-08
Pages: 115
USD 2900.00 (Single User License)Global 25G Transconjunctival Sutureless Vitrectomy System Market Outlook, In‑Depth Analysis & Forecast to 2031
The global 25G Transconjunctival Sutureless Vitrectomy System market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 141
USD 4900.00 (Single User License)Global 25G Transconjunctival Sutureless Vitrectomy System Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global 25G Transconjunctival Sutureless Vitrectomy System market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 77
USD 4250.00 (Single User License)25G Transconjunctival Sutureless Vitrectomy System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for 25G Transconjunctival Sutureless Vitrectomy System was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 98
USD 3950.00 (Single User License)Global 25G Transconjunctival Sutureless Vitrectomy System Market Research Report 2025
The global market for 25G Transconjunctival Sutureless Vitrectomy System was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 87
USD 2900.00 (Single User License)Global 25G Transconjunctival Sutureless Vitrectomy System Market Insights, Forecast to 2030
The 25G transconjunctival sutureless vitrectomy system is a vitrectomy surgery performed with minimal trauma. It uses a special trocar to directly puncture the bulbar conjunctiva and sclera to enter the vitreous cavity for surgery. The surgical incision is significantly reduced and no suture is required, so it is called "minimally traumatic" surgery. The system is mainly composed of microcannulas, cannula puncture needles, perfusion tubes, cannula plugs and plug forceps. Among them, the diameters of the cannulas and surgical instruments are very small, so that only three very small needle holes (0.5 mm in diameter) are needed to pass through the wall of the eyeball. The perfusion tube and surgical instruments are inserted into the eyeball through the cannula, and no sutures are required to fix them.
Published: 2024-10-31
Pages: 134
USD 4900.00 (Single User License)25G Transconjunctival Sutureless Vitrectomy System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The 25G transconjunctival sutureless vitrectomy system is a vitrectomy surgery performed with minimal trauma. It uses a special trocar to directly puncture the bulbar conjunctiva and sclera to enter the vitreous cavity for surgery. The surgical incision is significantly reduced and no suture is required, so it is called "minimally traumatic" surgery. The system is mainly composed of microcannulas, cannula puncture needles, perfusion tubes, cannula plugs and plug forceps. Among them, the diameters of the cannulas and surgical instruments are very small, so that only three very small needle holes (0.5 mm in diameter) are needed to pass through the wall of the eyeball. The perfusion tube and surgical instruments are inserted into the eyeball through the cannula, and no sutures are required to fix them.
Published: 2024-10-31
Pages: 100
USD 3950.00 (Single User License)Global 25G Transconjunctival Sutureless Vitrectomy System Market Research Report 2024
The 25G transconjunctival sutureless vitrectomy system is a vitrectomy surgery performed with minimal trauma. It uses a special trocar to directly puncture the bulbar conjunctiva and sclera to enter the vitreous cavity for surgery. The surgical incision is significantly reduced and no suture is required, so it is called "minimally traumatic" surgery. The system is mainly composed of microcannulas, cannula puncture needles, perfusion tubes, cannula plugs and plug forceps. Among them, the diameters of the cannulas and surgical instruments are very small, so that only three very small needle holes (0.5 mm in diameter) are needed to pass through the wall of the eyeball. The perfusion tube and surgical instruments are inserted into the eyeball through the cannula, and no sutures are required to fix them.
Published: 2024-10-31
Pages: 80
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now